513 related articles for article (PubMed ID: 26376733)
41. Coexistence of cervical extramedullary plasmacytoma and squamous cell carcinoma: A case report.
Zhang QY; Li TC; Lin J; He LL; Liu XY
World J Clin Cases; 2021 Aug; 9(24):7110-7116. PubMed ID: 34540966
[TBL] [Abstract][Full Text] [Related]
42. Circulating Epstein-Barr virus microRNAs miR-BART7 and miR-BART13 as biomarkers for nasopharyngeal carcinoma diagnosis and treatment.
Zhang G; Zong J; Lin S; Verhoeven RJ; Tong S; Chen Y; Ji M; Cheng W; Tsao SW; Lung M; Pan J; Chen H
Int J Cancer; 2015 Mar; 136(5):E301-12. PubMed ID: 25213622
[TBL] [Abstract][Full Text] [Related]
43. Extramedullary plasmacytoma of the head and neck: use of paraffin sections to assess clonality with in situ hybridization, growth fraction, and the presence of Epstein-Barr virus.
Aguilera NS; Kapadia SB; Nalesnik MA; Swerdlow SH
Mod Pathol; 1995 Jun; 8(5):503-8. PubMed ID: 7675768
[TBL] [Abstract][Full Text] [Related]
44. Uncommon presentation of nasopharyngeal extramedullary plasmacytoma: a case report and literature review.
Manganaris A; Conn B; Connor S; Simo R
B-ENT; 2010; 6(2):143-6. PubMed ID: 20681370
[TBL] [Abstract][Full Text] [Related]
45. Leukemoid reaction associated with pediatric nasopharyngeal carcinoma: An unusual presentation.
Kuş AB; Şahin P; Uğuz AH; Tanyeli A; Küpeli S
Int J Pediatr Otorhinolaryngol; 2014 May; 78(5):885-7. PubMed ID: 24646685
[TBL] [Abstract][Full Text] [Related]
46. [Extramedullary plasmacytoma of the head and neck: a clinicopathologic, immunohistochemistry study].
Zhou GY; Gao BQ; Liu YF; Zhang XL; Wang JQ
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2000 Apr; 14(4):168-70. PubMed ID: 12541493
[TBL] [Abstract][Full Text] [Related]
47. Synchronous presentation of extramedullary plasmacytoma in the nasopharynx and the larynx.
Iseri M; Ozturk M; Ulubil SA
Ear Nose Throat J; 2009 Nov; 88(11):E9-12. PubMed ID: 19924656
[TBL] [Abstract][Full Text] [Related]
48. Difficulty in diagnosis of nasopharyngeal carcinoma.
Siddique MA; Sabur MA; Kundu SC; Mostafa MG; Khan JA; Ahmed S; Karim MA; Hanif MA
Mymensingh Med J; 2012 Jan; 21(1):158-61. PubMed ID: 22314474
[TBL] [Abstract][Full Text] [Related]
49. Clinical and histological characteristics of nasopharyngeal cancer in Sokoto, north-western, Nigeria.
Iseh KR; Abdullahi A; Malami SA
West Afr J Med; 2009 May; 28(3):151-5. PubMed ID: 20306729
[TBL] [Abstract][Full Text] [Related]
50. Expression of potential therapeutic target SSTR2a in primary and metastatic non-keratinizing nasopharyngeal carcinoma.
Tao L; Chen Y; Shi X; Yu G; Yin W; Huang Y
Virchows Arch; 2020 Oct; 477(4):573-579. PubMed ID: 32328798
[TBL] [Abstract][Full Text] [Related]
51. Nasopharyngeal carcinoma, with emphasis on its relationship to Epstein-Barr virus.
Vasef MA; Ferlito A; Weiss LM
Ann Otol Rhinol Laryngol; 1997 Apr; 106(4):348-56. PubMed ID: 9109729
[TBL] [Abstract][Full Text] [Related]
52. Reticular and myxoid non-keratinizing nasopharyngeal carcinoma: an unusual case mimicking a salivary gland carcinoma.
Petersson F; Vijayadwaja D; Loh KS; Tan KB
Head Neck Pathol; 2014; 8(3):364-8. PubMed ID: 24323539
[TBL] [Abstract][Full Text] [Related]
53. Baicalein inhibits growth of Epstein-Barr virus-positive nasopharyngeal carcinoma by repressing the activity of EBNA1 Q-promoter.
Zhang Y; Wang H; Liu Y; Wang C; Wang J; Long C; Guo W; Sun X
Biomed Pharmacother; 2018 Jun; 102():1003-1014. PubMed ID: 29710517
[TBL] [Abstract][Full Text] [Related]
54. Epstein-Barr virus-encoded RNAs as a survival predictor in nasopharyngeal carcinoma.
Ke K; Wang H; Fu S; Zhang Z; Duan L; Liu D; Ye J
Chin Med J (Engl); 2014; 127(2):294-9. PubMed ID: 24438619
[TBL] [Abstract][Full Text] [Related]
55. Recurrent epistaxis in a nine-year-old boy: benign or malignant?
Dean HF; Hadjisymeou S; Morrison G; Hore I
J Laryngol Otol; 2015 Mar; 129(3):293-5. PubMed ID: 25797451
[TBL] [Abstract][Full Text] [Related]
56. Noninvasive diagnosis of nasopharyngeal carcinoma: nasopharyngeal brushings reveal high Epstein-Barr virus DNA load and carcinoma-specific viral BARF1 mRNA.
Stevens SJ; Verkuijlen SA; Hariwiyanto B; Harijadi ; Paramita DK; Fachiroh J; Adham M; Tan IB; Haryana SM; Middeldorp JM
Int J Cancer; 2006 Aug; 119(3):608-14. PubMed ID: 16572427
[TBL] [Abstract][Full Text] [Related]
57. Epidemiologic evidence of superior outcomes for extramedullary plasmacytoma of the head and neck.
Gerry D; Lentsch EJ
Otolaryngol Head Neck Surg; 2013 Jun; 148(6):974-81. PubMed ID: 23482476
[TBL] [Abstract][Full Text] [Related]
58. Nasopharyngeal Epstein-Barr Virus Load: An Efficient Supplementary Method for Population-Based Nasopharyngeal Carcinoma Screening.
Chen Y; Zhao W; Lin L; Xiao X; Zhou X; Ming H; Huang T; Liao J; Li Y; Zeng X; Huang G; Ye W; Zhang Z
PLoS One; 2015; 10(7):e0132669. PubMed ID: 26151639
[TBL] [Abstract][Full Text] [Related]
59. Epstein-Barr virus DNA load in nasopharyngeal brushings and whole blood in nasopharyngeal carcinoma patients before and after treatment.
Adham M; Greijer AE; Verkuijlen SA; Juwana H; Fleig S; Rachmadi L; Malik O; Kurniawan AN; Roezin A; Gondhowiardjo S; Atmakusumah D; Stevens SJ; Hermani B; Tan IB; Middeldorp JM
Clin Cancer Res; 2013 Apr; 19(8):2175-86. PubMed ID: 23493345
[TBL] [Abstract][Full Text] [Related]
60. Prognostic role of tumor infiltrating lymphocytes in EBV positive and EBV negative nasopharyngeal carcinoma.
Ooft ML; van Ipenburg JA; Braunius WW; Zuur CI; Koljenović S; Willems SM
Oral Oncol; 2017 Aug; 71():16-25. PubMed ID: 28688685
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
